生物活性 | |||
---|---|---|---|
描述 | Amitriptyline hydrochloride acts as an inhibitor of the serotonin reuptake transporter (SERT) and the noradrenaline reuptake transporter (NET), with inhibition constants (Kis) of 3.45 nM for SERT and 13.3 nM for NET in humans. Additionally, it has a low affinity for the dopamine reuptake transporter (DAT) with a Ki of 2.58 μM. Amitriptyline hydrochloride also blocks adrenergic, muscarinic, histamine, and 5-HT receptors. It serves as an agonist for TrkA and TrkB receptors, demonstrating strong neurotrophic properties. Amitriptyline hydrochloride is recognized for its antidepressant efficacy[1].[2].[3]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT03168022 | Healthy Adults | Phase 1 | Completed | - | Canada ... 展开 >> InVentiv Health Clinique Inc. Quebec, Canada, GIP )A2 收起 << |
NCT02814565 | Neck Pain Bac... 展开 >>k Pain Spasm 收起 << | Phase 3 | Completed | - | Russian Federation ... 展开 >> Lipetsk, Lipetsk region, Russian Federation Saransk, Republic of Mordovia, Russian Federation Kazan, Republic of Tatarstan, Russian Federation Ekaterinburg, Sverdlovsk region, Russian Federation Moscow, Russian Federation Nizhny Novgorod, Russian Federation Novosibirsk, Russian Federation Saint-Petersburg, Russian Federation Tver, Russian Federation Yaroslavl, Russian Federation 收起 << |
NCT01266733 | Fibromyalgia | Phase 2 | Completed | - | Spain ... 展开 >> Hospital Galdakao-Usansolo Galdakao, Bizkaia, Spain, 48960 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.19mL 0.64mL 0.32mL |
15.93mL 3.19mL 1.59mL |
31.86mL 6.37mL 3.19mL |
参考文献 |
---|